Evidence map›Paper›PMID 37641864›Full record

ArticleThe EMBO journal2023

Changes in adenoviral chromatin organization precede early gene activation upon infection.

Uwe Schwartz, Tetsuro Komatsu, Claudia Huber, Floriane Lagadec, Conradin Baumgartl, Elisabeth Silberhorn, Margit Nuetzel, Fabienne Rayne, Eugenia Basyuk, Edouard Bertrand and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Distinct YY dinucleotide periodicity in adeno-associated virus DNA.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Global cis-regulatory landscape of double-stranded DNA viruses.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Mysteries of adenovirus packaging.Journal of virology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Uwe SchwartzBiochemie Zentrum Regensburg, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-7628-2687
Tetsuro KomatsuLaboratory of Epigenetics and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan.ORCID 0000-0003-3963-8792
Claudia HuberBiochemie Zentrum Regensburg, University of Regensburg, Regensburg, Germany.
Floriane LagadecCNRS UMR 5234, Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, Bordeaux, France.ORCID 0000-0001-9425-1190
Conradin BaumgartlBiochemie Zentrum Regensburg, University of Regensburg, Regensburg, Germany.
Elisabeth SilberhornBiochemie Zentrum Regensburg, University of Regensburg, Regensburg, Germany.
Margit NuetzelDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Fabienne RayneCNRS UMR 5234, Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, Bordeaux, France.ORCID 0000-0003-0713-1137
Eugenia BasyukCNRS UMR 5234, Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, Bordeaux, France.
Edouard BertrandCNRS UMR 5355, Institut de Généthique Moléculaire de Montpellier, Montpellier, France.
Michael RehliDepartment of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
Harald WodrichCNRS UMR 5234, Microbiologie Fondamentale et Pathogénicité, Université de Bordeaux, Bordeaux, France.ORCID 0000-0002-4764-1708
Gernot LaengstBiochemie Zentrum Regensburg, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-8232-1179
Centre National de la Recherche Scientifique · FRUniversity of Regensburg · DEUniversity Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Within the virion, adenovirus DNA associates with the virus-encoded, protamine-like structural protein pVII. Whether this association is organized, and how genome packaging changes during infection and subsequent transcriptional activation is currently unclear. Here, we combined RNA-seq, MNase-seq, ChIP-seq, and single genome imaging during early adenovirus infection to unveil the structure- and time-resolved dynamics of viral chromatin changes as well as their correlation with gene transcription. Our MNase mapping data indicates that the adenoviral genome is arranged in precisely positioned nucleoprotein particles with nucleosome-like characteristics, that we term adenosomes. We identified 238 adenosomes that are positioned by a DNA sequence code and protect about 60-70 bp of DNA. The incoming adenoviral genome is more accessible at early gene loci that undergo additional chromatin de-condensation upon infection. Histone H3.3 containing nucleosomes specifically replaces pVII at distinct genomic sites and at the transcription start sites of early genes. Acetylation of H3.3 is predominant at the transcription start sites and precedes transcriptional activation. Based on our results, we propose a central role for the viral pVII nucleoprotein architecture, which is required for the dynamic structural changes during early infection, including the regulation of nucleosome assembly prior to transcription initiation. Our study thus may aid the rational development of recombinant adenoviral vectors exhibiting sustained expression in gene therapy.

Indexed as

ChromatinNucleosomesAdenoviridaeChromatin Assembly and DisassemblyDNATranscriptional ActivationChromatinDNANucleosomesadenoviruschromatin remodelingearly infectionpVIItranscription

Identifiers

PMID37641864
PMCPMC10548178
OpenAlexW4386253661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.